At a glance
- Originator Kowa
- Class Antirheumatics
- Mechanism of Action Cytokine inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatoid arthritis
Most Recent Events
- 25 Jun 2010 No development reported - Phase-II for Rheumatoid arthritis in European Union (PO)
- 13 Jun 2008 Phase II development is ongoing
- 28 Feb 2006 This compound is still in active development